DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
The DEA increases production quotas for psychedelics like psilocybin and ibogaine, while marijuana quotas remain stable ahead of a possible rescheduling decision.
